Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-08-21
2010-10-12
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S213010, C514S220000
Reexamination Certificate
active
07812015
ABSTRACT:
The invention relates to the use of inhibitors of acid sphingomyelinase and/or of inhibitors of products of the reaction catalyzed by this enzyme, for the prophylaxis and/or treatment of infectious diseases and/or diseases which are influenced by infections during the course thereof. The cited products especially include ceramide. Preferrably neutralizing antibodies and/or antidepressants, especially tricyclic and/or tetracyclic antidepressants, are used as inhibitors.
REFERENCES:
patent: 5233024 (1993-08-01), Schreiber et al.
patent: 5244881 (1993-09-01), Coutel-Egros
patent: 5373005 (1994-12-01), McCann et al.
patent: 5569677 (1996-10-01), Daines
patent: 6248528 (2001-06-01), Chen et al.
patent: 6608101 (2003-08-01), Sikorski et al.
patent: 2002/0177126 (2002-11-01), Young et al.
patent: 2005/0054588 (2005-03-01), Borody
patent: 90/14089 (1990-11-01), None
patent: 99/41373 (1999-08-01), None
patent: 00/33885 (2000-06-01), None
patent: 00/56890 (2000-09-01), None
Haimovitz-Friedman, A. et al. “Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation,” (1997). J. Exp. Med., 186 (11):1831-1841.
Webster Ninth New Collegiate Dictionary. 2000. Definition of Prevent. p. 1.
Nature Medicine, Mar. 2003, vol. 9, No. 3, pp. 322-330.
Bilgi et al. Canadian Family Physician. May 1979; vol. 25, pp. 619-620, 622, 624-625.
New York Times. Dec. 1997, Inhalant Drug Approved for Cystic Fibrosis, pp. 1-3.
Sanders et al. Am J. Respir. Crit. Care Med., 2000, vol. 162, pp. 1905-1911.
Baillie, R. The Lancet, 1967, pp. 369-370.
Albouz, S., et al., “Effect of Tricyclic Antidepressants on Sphingomyelinase and Other Sphingolipid Hydrolases in C6 Cultured Glioma Cells”,Neuroscience Letters, vol. 36, No. 3, pp. 311-315, (1983). XP008023932.
Baumann, N., et al., “Effect of Tricyclic Antidepressants on Lysosomal Sphingomyelinase Activity”,NATO ASI Series, Series A: Life Sciences, vol. 150 (Lipid Storage Disord.), pp. 627-634, (1988). XP008023933.
Brown, D.A., et al., “Functions of Lipid Rafts in Biological Membranes”,Annu. Rev. Cell Dev. Biol., vol. 14, pp. 111-136, (1998).
Clapham, P.R., et al., “HIV-1 Receptors and Cell Tropism”,British Medical Bulletin, vol. 58, pp. 43-59, (2001).
Claus, S.R., et al., “Modulation of the Ceramide Level, A Novel Therapeutic Concept?”,Current Drug Targets, vol. 1, No. 2, pp. 185-205, (2000).
Dutta, P., et al., “Antimalarial Properties of Imipramine and Amitriptyline”,J. Protozool., vol. 37, No. 1, pp. 54-58, (1990).
Grassmé, H., et al., “Acidic Spingomyelinase Mediates Entry of N. Gonorrhoeae Into Nonphagocytic Cells”,Cell, vol. 91, pp. 605-615, (1997).
Grassmé, H., et al., “CD95 Signaling Via Ceramide-Rich Membrane Rafts”,The Journal of Biological Chemistry, vol. 276, No. 23, pp. 20589-20596, (2001).
Grassmé, H., et al., “Ceramide-Rich Membrane Rafts Mediate CD40 Clustering”,The Journal of Immunology, pp. 298-307, (2001).
Harder, T., et al., “Caveolae, DIGs, and the Dynamics of Sphingolipid-Cholesterol Microdomains”,Current Opinion in Cell Biology, vol. 9, pp. 534-542, (1997).
Hauck, C.R., et al., “Acid Sphingomyelinase is Involved in CEACAM Receptor-Mediated Phagocytosis ofNeisseria gonorrhoeae”, FEBS Letters, vol. 478, pp. 260-266, (2000).
Kristiansen, J.E., et al., “Inhibition of HIV Replication by Neuroleptic Agents and Their Potential Use in HIV Infected Patients With AIDS Related Dementia”,International Journal of Antimicrobial Agents, vol. 14, pp. 209-213, (2000). XP001056998.
Lauer, S.A., et al., “Sphingolipid Synthesis as a Target for Chemotherapy Against Malaria Parasites”,Proc. Natl. Acad. Sci. USA, vol. 92, pp. 9181-9185, (1995).
Munoz-Bellido, J.L., et al., “Antimicrobial Activity of Psychotropic Drugs Selective Serotonin Reuptake Inhibitors”,International Journal of Antimicrobial Agents, vol. 14, pp. 177-180, (2000).
Popik, W., et al., “Human Immunodeficiency Virus Type 1 Uses Lipid Raft-Colocalized CD4 and Chemokine Receptors for Productive Entry Into CD4+T Cells”,Journal of Virologyvol. 76, No. 10, pp. 4709-4722, (2002).
W. Linli, “Clinical Application and Adverse Reaction of Nystatin”.China Pharmacaceuticals, vol. 10:1, pp. 58-59, 2001.
Prince et al., “KGF alters gene expression in human airway epithelia: potential regulation of the inflammatory response.”Physiol. Genomics, v. 6, pp. 87-89, 2001.
Shute et al., “Growth Factors in cystic fibrosis—when is not enough.”Paediatric Respiratory Reviews, v. 4, pp. 120-127, 2003.
Alfsen et al., “Secretory IgA Specific for a Conserved Epitope on gp41 Envelope Glycoprotein Inhibits Epithelial Transcytosis of HIV-1” Journal of Immunology (2001) 166:6257-6265.
Corda et al., “Rapid Reactive Oxygen Species Production by Mitochondria in Endothelial Cells Exposed to Tumor Necrosis Factor-alpha is Mediated by Ceramide” Am. J. Respir. Cell Mol. Biol. (2001) 24:763-768.
Gajate et al., “The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells” Blood (2001) 98:3860-3883.
Rousson et al., “Preparation of an anti-acid sphingomyelinase monoclonal antibody for the quantitative determination and polypeptide analysis of lysosomal sphingomyelinase in fibroblasts from normal and Niemann-Pick type A patients” J. Immunol. Methods (1993) 160:199-206.
Triantafilou et al., “Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation” Journal of Cell Science (2002) 115:2603-2611.
Vielhaber et al. “Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide” Glycobiology (2001) 11(6):451-457.
Asay, “Cyctic Fibrosis” California Medicine, 102:292-300 (1965).
Corda et al., “Rapid Reactive Oxygen Species Production by Mitochondria in Endothelial Cells Exposed to Tumor Necrosis Factor-alpha is Mediated by Ceramide” Am J Respir Cell Mol Biol, 24(6):762-8 (2001).
Hurwitz et al., “The Tricyclic Antidepressant Desipramine Causes Proteolytic Degradation of Lysosomal Sphingomyelinase in Human Fibroblasts” biol Chem Hoppe Seyler, 375(7):447-50 (1994).
Adams Claus
Bozicevic Karl
Bozicevic Field & Francis LLP
Gülbins Erich
Jean-Louis Samira
LandOfFree
Prophylaxis and treatment of infectious diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylaxis and treatment of infectious diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylaxis and treatment of infectious diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200800